(UPDATED FEBRUARY 8) Last month’s granting of an Amgen permanent injunction motion in its cholesterol drug patent dispute with Sanofi and Regeneron would “give another arrow in the quiver” of those seeking permanent injunctions in similar cases, if it is upheld on appeal
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Beatriz Lima joins us for our ‘Five minutes with’ series to discuss a recent victory at the Unified Patent Court and the challenges of establishing your own firm
International intellectual property experts will be addressing AI, the Unified Patent Court, monetisation strategies, and more at the event in Munich in November
Former White & Case partner joins HSF Kramer’s New York office to head up US technology transactions practice and strengthen firm’s IP and tech capabilities
Molly Kocialski, who has joined Holland & Hart after nearly a decade as a USPTO regional director, discusses career shifts, resilience, and overcoming casual sexism